학술논문
B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY.
Document Type
Article
Author
Source
HemaSphere; Apr2022 Supplement 1, Vol. 6, p7-8, 2p
Subject
Language
ISSN
25729241